DRUG SAFETY SYMPOSIUM

Facebook
Twitter
WhatsApp

Advancing Excellence in Pharmaceutical Vigilance, Regulatory Affairs and Quality Assurance DATE: 14-15 February 2024 | VENUE: Holiday Inn & Suites, Dubai Science Park, Dubai

At the forefront of advancing drug safety, the maiden edition of Drug Safety Symposium is dedicated to upholding the highest standards through rigorous practices in pharmacovigilance, regulatory compliance, and quality assurance. Our esteemed Conference and Masterclass format serves as premier gathering, offering a dynamic platform for attendees to delve into the latest industry trends, stay abreast of regulatory changes, and unearth innovative solutions propelling the pharmaceutical industry into the future.
Committed to excellence, we foster an environment conducive to meaningful discussions, knowledge sharing, and collaboration. Our goal is to empower participants with insights that transcend traditional boundaries, ensuring a transformative and enriching experience. Join us as we navigate the evolving landscape of drug safety, shaping the future of pharmaceuticals through expertise, exploration, and collaboration.

Reasons to Attend
• Critically appraise the founding principles of pharmacovigilance and landmark cases effecting change to recent drug safety issue
• Explain key operational drug safety definitions
• Demonstrate good pharmacovigilance practice and locate key sources of information and documentation
• Critically discuss issues associated with global pharmacovigilance
• Analyse the stages of drug development in terms of drug safety assessment and benefit risk
• Critically explain the strengths and weakness of pharmacovigilance reporting systems
Identify and predict future challenges in drug safety and pharmacovigilance

Pharma Utility

Pharma Utility

Welcome to Pharma Utility, a magazine dedicated to news and services in the Indian pharmaceutical industry. Founded in the year 2007 by Mr. Digvijay Singh, in last 10 years we have moved leap and bound in making pharmacy knowledge available to all our partners.

Related Posts

Related Articles